Describing patients' normal tissue reactions: Concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity

International Journal of Cancer

Volumn 79, Issue 6, 1998, Pages 606-613

  Burnet, Neil G ^a   Johansen, Jørgen ^b   Turesson, Ingela ^c   Nyman, Jan ^d   Peacock, John H ^e  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; NOMENCLATURE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; RADIOTHERAPY; STATISTICAL ANALYSIS; TISSUE REACTION;

FOLLOW-UP STUDIES; HUMANS; RADIATION TOLERANCE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; REFERENCE VALUES; TERMINOLOGY;

EID: 0031737611     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981218)79:6<606::AID-IJC9>3.0.CO;2-Y     Document Type: Article

References (38)

1. BENTZEN, S.M., Potential clinical impact of normal tissue intrinsic radiosensitivity testing. Radiother. Oncol., 43, 121-131 (1997).
2. BENTZEN, S.M. and OVERGAARD, J., Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin. Radiat. Oncol., 4, 68-80 (1994).
3. BROCK, W.A., TUCKER, S.L., GEARA, F.B., TURESSON, I., WIKE, J., NYMAN, J. and PETERS, L.J., Fibroblast sensitivity versus acute and late normal skin response in patients treated for breast cancer. Int. J. Radiat. Oncol. Biol. Phys., 32, 1371-1379 (1995).
4. BURNET, N.G., NYMAN, J., TURESSON, I., WURM, R., YARNOLD, J.R. and PEACOCK, J.H., Improving radiotherapy cure rates by predicting normal tissue tolerance from in vitro cellular radiation sensitivity. Lancet, 339, 1570-1571 (1992).
5. BURNET, N.G., NYMAN, J., TURESSON, I., WURM, R., YARNOLD, J.R. and PEACOCK, J.H., The relationship between cellular radiation sensitivity and tissue response to radiotherapy may provide the basis for individualising radiotherapy schedules. Radiother. Oncol., 33, 228-238 (1994).
6. BURNET, N.G., WURM, R., NYMAN, J. and PEACOCK, J.H., Normal tissue radiosensitivity - how important is it? Clin. Oncol., 8, 25-34 (1996a).
7. BURNET, N.G., WURM, R. and PEACOCK, J.H., Low dose-rate fibroblast response: the correct measure of fibroblast radiosensitivity for the prediction of patient response to radiotherapy? Int. J. Radiat. Biol., 70, 289-300 (1996b).
8. CHU, F.C.H., GLICKSMAN, A.S. and NICKSON, J.J., Late consequences of early skin reactions. Radiology, 94, 669-672 (1970).
9. DILETO, C.L. and TRAVIS, E.L., Fibroblast radiosensitivity in vitro and lung fibrosis in vivo: comparison between a fibrosis-prone and fibrosis-resistant mouse strain. Radiat. Res., 146, 61-67 (1996).
10. DUNST, J. and GEBHART, E., Unexpected tumour response, radiation myelitis and increased in vitro radiosensitivity of lymphocytes in a patient with non-small cell lung cancer. Radiother. Oncol., 36, 158 (1995).
11. GEARA, F.B., PETERS, L.J., ANG, K.K., WIKE, J.L. and BROCK, W.A., Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys., 27, 1173-1179 (1993).
12. GLICKSMAN, A.S., CHU, F.C.H., BANE, H.N. and NICKSON, J.J., Quantitative and qualitative evaluation of skin erythema. II. Clinical study in patients on a standardised irradiation schedule. Radiology, 75, 411-414 (1960).
13. HANLON, A.L., SCHULTHEISS, T.E., HUNT, M.A., MOVSAS, B., PETER, R.S. and HANKS, G.E., Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int. J. Radiat. Oncol. Biol. Phys., 38, 59-63 (1997).
14. HOLTHUSEN, H., Erfahrungen über die Verträglichkeitsgrenze für Röntgenstrahlen and deren Nutzanwendung zur Verhütung von Schäden. Strahlentherapie, 57, 254-269 (1936).
15. HUNTER, R.D., COWIE, V.J., BLAIR, V. and COLE, M.P., A clinical trial of two conceptually different radical radiotherapy treatments in stage III carcinoma of the cervix. Clin. Radiol., 37, 23-27 (1986).
16. JOHANSEN, J., BENTZEN, S.M., OVERGAARD, J. and OVERGAARD, M., Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int. J. Radiat. Biol., 66, 407-412 (1994).
17. JOHANSEN, J., BENTZEN, S.M., OVERGAARD, J. and OVERGAARD, M., Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother. Oncol., 40, 101-109 (1996).
18. JONES, L.A., SCOTT, D., COWAN, R. and ROBERTS, S.A., Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int. J. Radiat. Biol., 67, 519-528 (1995).
19. LATE EFFECTS OF NORMAL TISSUES CONSENSUS CONFERENCE, Int. J. Radiat. Oncol. Biol. Phys., 31, 1041-1364 (1995).
20. LITTLE, J.B. and NOVE, J., Sensitivity of human diploid fibroblast cell strains from various genetic disorders to acute and protracted radiation exposure. Radiat. Res., 123, 87-92 (1990).
21. LOEFFLER, J.S., HARRIS, J.R., DAHLBERG, W.K. and LITTLE, J.B., In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy from breast cancer. Radiat. Res., 121, 227-231 (1990).
22. MACKAY, R.I., NIEMIERKO, A., GOITEIN, M. and HENDRY, J.H., Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother. Oncol., 46, 215-216 (1998).
23. MEREDITH, W.J. and MASSEY, J.B., The measurement of X-ray quantity. In: Fundamental physics of radiology (3rd ed.), pp. 96-101, J. Wright, Bristol (1977).
24. MOODY, A.M., MAYLES, P.M., BLISS, J.M., A'HERN, R.P., OWEN, J.R., REGAN, J. and YARNOLD, J.R., The influence of breast size on late radiation effects and correlation with radiotherapy dose inhomogeneity. Radiother. Oncol., 33, 106-112 (1994).
25. NORMAN, A., KAGAN, A.R. and CHAN, S.L., The importance of genetics for the optimisation of radiation therapy. Amer. J. clin. Oncol., 11, 84-88 (1988).
26. NÚÑEZ, M.I., GUERRERO, M.R., LÓPEZ, E., DEL MORAL, M.R., VALENZUELA, M.T., SILES, E., VILLALOBOS, M., PEDRAZA, V., PEACOCK, J.H. and RUIZ DE ALMODÓVAR, M., DNA damage and prediction of radiation response in lymphocytes and epidermal skin cells. Int. J. Cancer, 76, 354-361 (1998).
27. PLOWMAN, P.N., BRIDGES, B.A., ARLETT, C.F., HINNEY, A. and KINGSTON, J.E., An instance of clinical morbidity and cellular radiosensitivity, not associated with ataxia-telangiectasia. Brit. J. Radiol., 63, 624-628 (1990).
28. RAMSAY, J. and BIRRELL, G., Normal tissue radiosensitivity in breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys., 31, 339-344 (1995).
29. RODEMANN, H.P. and BAMBERG, M., Cellular basis of radiation-induced fibrosis. Radiother. Oncol., 35, 83-90 (1995).
30. RUSSELL, N.S., KNAKEN, H., BRUINVIS, I.A.D., HART, A.A.M., BEGG, A.C. and LEBESQUE, J.V., Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy. Radiother. Oncol., 30, 213-221 (1994).
31. TUCKER, S.L., GEARA, F.B., PETERS, L.J. and BROCK, W.A., How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother. Oncol., 38, 103-113 (1996).
32. TUCKER, S.L., TURESSON, I. and THAMES, H.D., Evidence of individual differences in the radiosensitivity of human skin. Europ. J. Cancer, 28A, 1783-1791 (1992).
33. TURESSON, I., Individual variation and dose dependency in the progression rate of skin telangiectasia. Int. J. Radiat. Oncol. Biol. Phys., 19, 1569-1574 (1990).
34. TURESSON, I. and NOTTER, G., Skin reactions after different fractionation schedules giving the same cumulative radiation effect. Acta. Radiol. Ther. Phys. Biol., 14, 475-484 (1975).
35. TURESSON, I. NYMAN, J., HOLMBERG, E. and ODÉN, A., Prognostic factors for acute and late skin reactions in radiotherapy patients. Int. J. Radiat. Oncol., Biol. Phys., 36, 1065-1076 (1996).
36. TURESSON, I. and THAMES, H.D., Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation and telangiectasia after 3 and 5 years follow-up. Radiother. Oncol., 15, 169-188 (1989).
37. WITHERS, H.R., Biologic basis of radiation therapy. In: C.A. Perez and L.W. Brady (eds.), Principles and practice of radiation oncology (2nd ed.), pp. 64-98, Lippincott, Philadelphia (1992).
38. WOODS, W.G., BYRNE, T.D. and KIM, T.H., Sensitivity of cultured cells to gamma radiation in a patient exhibiting marked in vivo radiation sensitivity. Cancer, 62, 2341-2345 (1988).